alopecia areata

Patient Buzz Series: “Jello Skin” and Other Trends
“Jello Skin” is a term that dermatology patients – especially TikTok-using patients – may use in their next office visit. A facialist coined the term when describing glowing, bouncy skin with a lot of collagen similar to Jell-O gelatin. Are you up-to-date on the latest developments and trends in dermatology? Peruse this list of articles in the consumer press and learn about everything fro …
JDD Issue Highlights | April 2022
psoriasisThe April 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from injectable fillers, botulinum toxin in hidradenitis suppurativa, cannabis and cannabinoid product use, to psoriasis, melasma, onychomycosis and everything in between, we share this month’s issue highlights straight from the JDD …
psoriasis
Hair Loss- Friday Pop Quiz
A 36-year-old male presents to the dermatology clinic with the findings depicted in this image. He states that this is the only involved area, and he denies any other associated symptoms. Two 4-mm punch biopsies are performed, one from the affected area and one from the unaffected region. Which of the following histopathologic findings are most likely associated with in this condition? A. D …
Lichen Planopilaris and Frontal Fibrosing Alopecia: Treatment Algorithms
lichen planopilaris and frontal fibrosing alopeciaDr. Jerry Shapiro, or the “Lord of the Hair” (as described by ODAC conference co-chair Dr. Adam Friedman) provided us with an A to Z overview of frontal fibrosing alopecia (FFA) and lichen planopilaris (LPP) as well royalty-worthy pearls and treatment updates. Before we start, here are my favorite quotes from Dr. Shapiro, which also serve as a great summary of his wonderful lecture: “Fro …
lichen planopilaris and frontal fibrosing alopecia
Dupilumab Therapeutic Cheat Sheet
DupilumabAtopic dermatitis (AD) is a common skin condition characterized by pruritus and occurs as a result of factors related to impaired skin barrier and immune response, as well as environmental and infectious agents. Patients with poor control on topical therapy are looking for safe and effective systemic treatments. We continue our series, Therapeutic Cheat Sheet, with a closer look at dupilumab, whic …
Dupilumab